Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 7,435 shares at $190.09 ($1.4M) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $1.4M RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $188.69 | 656 | $124K | 8.7% |
| 2 | $188.69 | 656 | $124K | 8.7% |
| 3 | $190.09 | 1,333 | $253K | 17.8% |
| 4 | $190.09 | 1,333 | $253K | 17.8% |
| 5 | $190.50 | 202 | $38K | 2.7% |
| 6 | $192.74 | 918 |
| $177K |
| 12.4% |
| 7 | $192.74 | 918 | $177K | 12.4% |
| 8 | $193.88 | 218 | $42K | 3.0% |
| 9 | $195.16 | 571 | $111K | 7.8% |
| 10 | $195.16 | 571 | $111K | 7.8% |
| 11 | $195.77 | 59 | $12K | 0.8% |
| Total | $191.44 avg | 7,435 | $1.4M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |